Garzino-Demo A - Search Results

1

Copy number variation of defensin genes and HIV infection in Brazilian children.

Milanese M, Segat L, Arraes LC, Garzino-Demo A, Crovella S. Milanese M, et al. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):331-3. doi: 10.1097/QAI.0b013e3181945f39. J Acquir Immune Defic Syndr. 2009. PMID: 19194307

2

The θ-defensin retrocyclin 101 inhibits TLR4- and TLR2-dependent signaling and protects mice against influenza infection.

Prantner D, Shirey KA, Lai W, Lu W, Cole AM, Vogel SN, Garzino-Demo A. Prantner D, et al. J Leukoc Biol. 2017 Oct;102(4):1103-1113. doi: 10.1189/jlb.2A1215-567RR. Epub 2017 Jul 20. J Leukoc Biol. 2017. PMID: 28729359 Free PMC article.

3

Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells.

Lafferty MK, Sun L, Christensen-Quick A, Lu W, Garzino-Demo A. Lafferty MK, et al. Viruses. 2017 May 16;9(5):111. doi: 10.3390/v9050111. Viruses. 2017. PMID: 28509877 Free PMC article.

4

Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages.

Bharucha JP, Sun L, Lu W, Gartner S, Garzino-Demo A. Bharucha JP, et al. Front Cell Infect Microbiol. 2021 Jul 1;11:535352. doi: 10.3389/fcimb.2021.535352. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34277460 Free PMC article.

5

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, Berrone S, Kleinman C, Wu Z, Abdelwahab S, Lu W, Garzino-Demo A. Sun L, et al. J Virol. 2005 Nov;79(22):14318-29. doi: 10.1128/JVI.79.22.14318-14329.2005. J Virol. 2005. PMID: 16254366 Free PMC article.

6

New targets for HIV drug discovery.

Puhl AC, Garzino Demo A, Makarov VA, Ekins S. Puhl AC, et al. Drug Discov Today. 2019 May;24(5):1139-1147. doi: 10.1016/j.drudis.2019.03.013. Epub 2019 Mar 15. Drug Discov Today. 2019. PMID: 30885676 Free PMC article. Review.

7

Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection.

Lusso P, Garzino-Demo A, Crowley RW, Malnati MS. Lusso P, et al. J Exp Med. 1995 Apr 1;181(4):1303-10. doi: 10.1084/jem.181.4.1303. J Exp Med. 1995. PMID: 7699322 Free PMC article.

8

Novel drugs targeting Toll-like receptors for antiviral therapy.

Patel MC, Shirey KA, Pletneva LM, Boukhvalova MS, Garzino-Demo A, Vogel SN, Blanco JC. Patel MC, et al. Future Virol. 2014 Sep;9(9):811-829. doi: 10.2217/fvl.14.70. Future Virol. 2014. PMID: 25620999 Free PMC article.

9

Chemokines and defensins as HIV suppressive factors: an evolving story.

Garzino-Demo A. Garzino-Demo A. Curr Pharm Des. 2007;13(2):163-72. doi: 10.2174/138161207779313696. Curr Pharm Des. 2007. PMID: 17269925 Review.

10

Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.

Christensen-Quick A, Lafferty M, Sun L, Marchionni L, DeVico A, Garzino-Demo A. Christensen-Quick A, et al. J Virol. 2016 Aug 12;90(17):7833-47. doi: 10.1128/JVI.02869-15. Print 2016 Sep 1. J Virol. 2016. PMID: 27334595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters